Chlormadinone acetate in progestin‐primed ovarian stimulation does not negatively affect clinical results
Abstract Purpose To investigate whether progestin‐primed ovarian stimulation (PPOS) with chlormadinone acetate (CMA) adversely affects clinical results and neonatal outcomes, or causes congenital deformities. Methods This retrospective study was conducted at private IVF clinic from November 2018 to...
Збережено в:
| Автори: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Wiley
2023-01-01
|
| Серія: | Reproductive Medicine and Biology |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1002/rmb2.12519 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|